发明名称 Defective influenza virus particles
摘要 The invention relates to the field of influenza virus and the vaccination against flu. The invention provides a conditionally defective influenza virus particle having seven different influenza nucleic acid segments. The invention also provides a conditionally defective influenza virus particle lacking an influenza nucleic acid segment selected from the group of segments essentially encoding acidic polymerase (PA), the basic polymerase 1 (PB1) and the basic polymerase 2 (PB2). In particular, the invention provides defective influenza virus particles having seven different influenza nucleic acid segments and lacking an influenza nucleic acid segment essentially encoding acidic polymerase. Furthermore, the invention provides use of a composition comprising a defective influenza virus particle according to the invention for the production of a pharmaceutical composition directed at generating immunological protection against infection of a subject with an influenza virus, and provides a method for generating immunological protection against infection of a subject with an influenza virus comprising providing a subject in need thereof with a composition comprising such defective influenza virus particle.
申请公布号 EP2272950(A3) 申请公布日期 2011.07.20
申请号 EP20100182312 申请日期 2005.11.08
申请人 ABBOTT BIOLOGICALS B.V.;ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM 发明人 DE WIT, EMMIE;SPRONKEN, MONIQUE I.J.;FOUCHIER, RON A.M.;OSTERHAUS, ALBERT D.M.E.
分类号 C12N7/04;A61K39/145;A61K48/00;C12N5/10;C12N7/02;C12N15/86 主分类号 C12N7/04
代理机构 代理人
主权项
地址